IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Operating cash flow 2016–2025
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$302.4MFY2025 · since FY2016: -$32.7M → -$302.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$302.4M | +14.3% |
| FY2024 | -$353.0M | +2.4% |
| FY2023 | -$361.8M | -23.6% |
| FY2022 | -$292.8M | -28.4% |
| FY2021 | -$227.9M | -11.1% |
| FY2020 | -$205.1M | -29.1% |
| FY2019 | -$158.9M | -56.9% |
| FY2018 | -$101.2M | -28.6% |
| FY2017 | -$78.7M | -140.9% |
| FY2016 | -$32.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice